☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
osteoporosis
Naitive Technologies Join Forces with Parvizi Surgical Innovation to Advance Osteoporosis Detection
November 7, 2024
Alvotech Reports the EMA’s Acceptance of MAA for AVT03 (Biosimilar, Prolia and Xgeva)
October 10, 2024
GlycoNex Reports the Completion of P-I Study Assessing SPD8 (Biosimilar, Prolia) for Osteoporosis
August 16, 2024
Alvotech Reports Data from Confirmatory Trial of AVT03 (Biosimilar, Prolia and Xgeva)
July 3, 2024
Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)
June 12, 2024
Fresenius Reports the US FDA’s BLA Acceptance of FKS518 (Biosimilar, Denosumab)
May 28, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.